The Role of Affect Regulation and Self-presentation in the Expressive Writing Intervention
NCT ID: NCT00831727
Last Updated: 2016-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2009-02-28
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The second aim of the study has two related objectives. First, we will attempt to investigate whether the expressive writing intervention can increase and enhance an individual's emotion regulation abilities. Related to this, we will then go on to examine whether emotion regulation can be looked at as a potential mechanism of action in the expressive writing procedure. Related to these two objectives, we hypothesize that in comparison to the control group, participants in the expressive writing condition will show increases in their ability to regulate their emotions from baseline to four week follow up. Moreover, we predict that greater gains in emotion regulation abilities for the expressive writing participants will be significantly related to greater gains in outcome measures.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Narrative Writing Duration and Post-writing Processing Instructions on PTSD
NCT01773811
Understanding and Intervening With State Shame and Self-criticism
NCT06200675
Examining Effects of a Therapeutic Focus on Positive Memories on Post-Trauma Health
NCT05523453
Emotional Awareness and Expression Therapy for Patients With Persistent Physical Symptoms in Routine Psychiatric Care: A Pilot Study
NCT06631911
Empathy in Post-traumatic Stress Disorder in Comparaison to a Control Population
NCT05617781
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Expressive Writing
Expressive Writing
Participants will write about their experienced trauma for 20 minutes on each of three consecutive days using techniques associated with expressive writing
Control
Control
Participants will write as factually as possible about an assigned trivial topic for 20 minutes on each of three consecutive days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Expressive Writing
Participants will write about their experienced trauma for 20 minutes on each of three consecutive days using techniques associated with expressive writing
Control
Participants will write as factually as possible about an assigned trivial topic for 20 minutes on each of three consecutive days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Previously experienced trauma (not current or ongoing; excluding bereavement)
* Currently experiencing trauma-related distress
Exclusion Criteria
* Currently taking psychotropic medications
* Imminent threat to self or others
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Justin Mattina
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeanne C Watson, Ph.D.
Role: STUDY_DIRECTOR
University of Toronto
Justin M Mattina, M.A.
Role: PRINCIPAL_INVESTIGATOR
University of Toronto
Jonathan J Danson, B.A.
Role: PRINCIPAL_INVESTIGATOR
University of Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ontario Institute for Studies in Education of the University of Toronto
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SSHRC 767-2007-2210-4
Identifier Type: -
Identifier Source: secondary_id
23614
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.